| India | Turchia | Austria | |
| Tomoterapia | da $5,200 | da $12,000 | da $30,000 |
| Terapia con protoni | da $25,000 | da $70,000 | da $80,000 |
| CyberKnife | da $6,000 | da $4,750 | da $50,000 |
| Criodistruzione | da $1,200 | da $3,500 | da $4,000 |
| Chemoembolizzazione del fegato | da $3,200 | da $7,500 | da $16,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Tumore epatico. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Tumore epatico e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Tumore epatico.
Il dottore ha completato un MD in Medicina Interna presso il Shyam Shah Medical College e ha svolto una Residenza Senior nello stesso dipartimento. Successivamente, il dottore ha servito come Registrar in Oncologia Medica presso il Jawaharlal Nehru Cancer Hospital. Il dottore ha completato la formazione DNB in Oncologia Medica presso l'Indraprastha Apollo Hospital.<\/p>
Durante la Residenza Senior, il dottore ha tenuto lezioni alla Scuola Internazionale Invernale di Oncologia presso l'AIIMS e ha presentato ricerche sul Cancro allo Stomaco al Simposio sul Cancro Gastrointestinale della Società Americana di Oncologia Clinica. Il dottore è specializzato nella base molecolare del cancro e nelle terapie mirate.<\/p>
Il medico ha ricevuto una formazione in Oncologia Chirurgica presso il Tata Memorial Hospital di Mumbai e ha completato il MRCS al Royal College of Surgeons di Edimburgo. Iniziando la pratica nel 2000, il medico ha fondato il Curie Manavata Cancer Centre nel 2007. Con 19 anni di esperienza, il medico ha eseguito oltre 50.000 interventi chirurgici per il cancro e ha partecipato a più di 200 studi clinici. Il medico è un autore pubblicato con numerose pubblicazioni internazionali e nazionali. Specializzandosi in Oncologia Chirurgica della Mammella e Toracica, il medico è professore per DNB Superspecialty Surgical Oncology e Breast Surgery presso MUHS.<\/p>
La dottoressa è un'oncologa altamente qualificata specializzata nel trattamento di vari tipi di cancro, inclusi tumori solidi, tumori pediatrici e malignità ematologiche. È esperta in trattamenti sia conservativi che chirurgici, come la procedura di Whipple.<\/p>
Ha completato il suo MBBS al Lady Hardinge Medical College e il MD in medicina interna al Maulana Azad Medical College. Ha proseguito con il DM in Oncologia Medica al Tata Memorial Hospital, dove ha anche lavorato come consulente.<\/p>
È affiliata a società oncologiche internazionali e nazionali e ha esperienza in tumori polmonari, mammari, ginecologici e genitourinari, con un particolare interesse per l'immunoterapia e la terapia metronomica.<\/p>
Liver cancer treatment in India centers on surgical resection, liver transplantation, and locoregional therapies. Indian hospitals utilize Barcelona Clinic Liver Cancer staging to personalize care. Options include radiofrequency ablation, chemoembolization, and stereotactic radiosurgery. Top facilities like Apollo and Medanta provide JCI-accredited care with outcomes comparable to Western standards.
Bookimed Expert Insight: Indian hospitals like Global Hospital Chennai and Medanta show a strong pattern of high-volume specialization. Global Hospital Chennai alone has performed over 1,000 liver transplants. This high volume often results in better procedural outcomes for complex oncology cases. Dr. Ravi Mohanka at Global Hospital Mumbai maintains an 88% patient survival rate across 1,300 transplants. Choosing these high-volume centers ensures access to surgeons who handle the most technically demanding liver procedures daily.
Patient Consensus: Patients note it is important to confirm if advanced drugs like Sorafenib are available as local generics. This can reduce monthly medication costs by up to 80% compared to international brands.
Liver cancer is curable in India when detected early. Specialist centers provide advanced surgical options like resection and living-donor transplants. Indian oncology centers report that 5-year survival rates for localized cases can exceed 80%. Early intervention is the primary factor for achieving a complete cure.
Bookimed Expert Insight: India has become a global leader in high-volume liver care. Our data shows centers like Manipal Hospitals serve over 2,000,000 patients annually. This massive scale allows surgeons like Dr. Ravi Mohanka to maintain an 88% survival rate through high procedural frequency. Choosing a high-volume facility often ensures access to complex multi-organ transplant expertise not found in smaller clinics.
Patient Consensus: Patients note that early detection is vital. Many highlight that local costs for procedures like radiofrequency ablation are approximately 70% lower than in Western countries while maintaining similar success rates.
Five-year survival rates for liver cancer in India vary by treatment and stage. Liver transplantation provides the highest outcomes with 70% to 85% survival. Surgical resection for early-stage cases yields 50% to 70% survival. Overall rates remain low due to frequent late-stage diagnoses.
Bookimed Expert Insight: High-volume centers show a clear correlation between clinical experience and survival. Dr. Ravi Mohanka at Global Hospital Mumbai has performed over 1,300 transplants with an 88% survival rate. Similarly, Dr. Raj Nagarkar at HCG Manavata has completed over 50,000 cancer surgeries. Patients should choose clinics like Global Hospital Chennai, which has performed over 1,000 liver transplants.
Patient Consensus: Patients emphasize that early screening catches significantly more treatable cases. Many note that outcomes at private hospitals are often better due to faster access to specialized care.
India is a global destination for high-volume liver cancer care. Leading institutions like Medanta, Apollo, and Global Hospital perform over 1,000 successful liver transplants and complex resections annually. These centers utilize advanced technologies like robotic-assisted surgery and CyberKnife to treat hepatocellular carcinoma with high success rates.
Bookimed Expert Insight: Patient volume directly correlates with safety in complex liver procedures. While many private facilities offer advanced robotic surgery, Global Hospital Chennai stands out for performing the world's first simultaneous liver transplant and spinal tuberculosis surgery. Selecting a facility with over 20,000 annual patients, such as Medanta, ensures the surgical team handles high-risk cases daily.
Patient Consensus: Patients often recommend getting second opinions from both Tata Memorial and private centers to compare tumor board reviews. Many note that high-volume spots like Apollo Chennai are better equipped for complex cases than smaller, newer facilities.
International patients should plan for an 8 to 12 week stay in India for a liver transplant. Less complex liver cancer surgeries typically require 3 to 5 weeks. These timelines include pre-operative testing, a 7 to 10 day hospital stay, and critical post-operative monitoring for rejection or complications.
Bookimed Expert Insight: Data shows that India’s top centers like Global Hospital Chennai and Apollo Hospital Indraprastha handle over 1,000,000 patients annually. While clinical guidelines suggest 3 weeks for resections, our records show patients often remain for 5 to 6 weeks. This extra time allows for managing unexpected issues like bile leaks before long-haul flights. Choosing a facility with over 1,000 successful transplants ensures the surgical team can manage these variations efficiently.
Patient Consensus: Patients emphasize the need for a 60-day medical visa and a financial buffer for extended lodging. Many advise staying in nearby serviced apartments to avoid the risks of traveling too soon after surgery.